Federico Grossi's most recent trade in Apellis Pharmaceuticals Inc was a trade of 2,500 Common Stock done at an average price of $48.8 . Disclosure was reported to the exchange on Jan. 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc | Federico Grossi | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 48.79 per share. | 05 Jan 2023 | 2,500 | 94,884 (0%) | 0% | 48.8 | 121,975 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.93 per share. | 01 Dec 2022 | 2,500 | 97,384 (0%) | 0% | 49.9 | 124,825 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.83 per share. | 01 Nov 2022 | 2,500 | 99,884 (0%) | 0% | 60.8 | 152,075 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 66.69 per share. | 03 Oct 2022 | 2,500 | 102,384 (0%) | 0% | 66.7 | 166,725 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.30 per share. | 01 Sep 2022 | 2,500 | 104,884 (0%) | 0% | 60.3 | 150,750 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 55.99 per share. | 01 Aug 2022 | 2,500 | 107,384 (0%) | 0% | 56.0 | 139,975 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 41.78 per share. | 01 Jun 2022 | 2,500 | 109,561 (0%) | 0% | 41.8 | 104,450 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Other type of transaction at price $ 0.00 per share. | 21 Apr 2022 | 11,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.56 per share. | 21 Apr 2022 | 2,500 | 112,061 (0%) | 0% | 43.6 | 108,900 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Other type of transaction at price $ 0.00 per share. | 21 Apr 2022 | 1,875 | 114,561 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 15 Mar 2022 | 7,000 | 116,811 (0%) | 0% | 4.3 | 30,170 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 7,000 | 50,723 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.57 per share. | 15 Mar 2022 | 375 | 116,436 (0%) | 0% | 39.6 | 14,839 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.53 per share. | 01 Mar 2022 | 375 | 109,811 (0%) | 0% | 43.5 | 16,324 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 23 Feb 2022 | 4,100 | 110,186 (0%) | 0% | 4.3 | 17,671 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 4,100 | 57,723 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.43 per share. | 15 Feb 2022 | 375 | 106,086 (0%) | 0% | 45.4 | 17,036 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 14 Feb 2022 | 3,600 | 106,461 (0%) | 0% | 4.3 | 15,516 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 3,600 | 61,823 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.12 per share. | 10 Feb 2022 | 705 | 102,861 (0%) | 0% | 47.1 | 33,220 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.58 per share. | 01 Feb 2022 | 375 | 103,566 (0%) | 0% | 40.6 | 15,218 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.59 per share. | 28 Jan 2022 | 650 | 103,941 (0%) | 0% | 38.6 | 25,084 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 36,951 | 36,951 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 26,051 | 104,591 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 3,400 | 65,423 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 14 Jan 2022 | 3,400 | 78,915 (0%) | 0% | 4.3 | 14,654 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.56 per share. | 14 Jan 2022 | 375 | 78,540 (0%) | 0% | 40.6 | 15,210 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 3,661 | 0 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 12 Jan 2022 | 3,661 | 74,015 (0%) | 0% | 3.8 | 13,765 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 1,500 | 68,823 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 12 Jan 2022 | 1,500 | 75,515 (0%) | 0% | 4.3 | 6,465 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 47.31 per share. | 03 Jan 2022 | 375 | 70,354 (0%) | 0% | 47.3 | 17,741 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.88 per share. | 15 Dec 2021 | 375 | 70,729 (0%) | 0% | 42.9 | 16,080 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 08 Dec 2021 | 7,000 | 71,104 (0%) | 0% | 3.8 | 26,320 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 7,000 | 3,661 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.40 per share. | 01 Dec 2021 | 375 | 64,104 (0%) | 0% | 42.4 | 15,900 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.50 per share. | 15 Nov 2021 | 625 | 64,479 (0%) | 0% | 43.5 | 27,188 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.70 per share. | 01 Nov 2021 | 625 | 64,805 (0%) | 0% | 30.7 | 19,188 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 34.57 per share. | 14 Oct 2021 | 750 | 65,430 (0%) | 0% | 34.6 | 25,928 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.26 per share. | 01 Oct 2021 | 750 | 66,180 (0%) | 0% | 33.3 | 24,945 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 28 Sep 2021 | 4,000 | 66,930 (0%) | 0% | 3.8 | 15,040 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Sep 2021 | 4,000 | 10,661 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 63.99 per share. | 02 Aug 2021 | 250 | 62,930 (0%) | 0% | 64.0 | 15,998 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 64.68 per share. | 14 Jul 2021 | 500 | 63,180 (0%) | 0% | 64.7 | 32,340 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 65.68 per share. | 08 Jul 2021 | 250 | 63,680 (0%) | 0% | 65.7 | 16,420 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 28 Jun 2021 | 9,000 | 63,930 (0%) | 0% | 3.8 | 33,840 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 9,000 | 14,661 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.39 per share. | 14 May 2021 | 500 | 55,430 (0%) | 0% | 45.4 | 22,695 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.73 per share. | 03 May 2021 | 600 | 55,614 (0%) | 0% | 50.7 | 30,438 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 14 Apr 2021 | 500 | 56,214 (0%) | 0% | 42.8 | 21,410 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.41 per share. | 01 Apr 2021 | 600 | 56,714 (0%) | 0% | 43.4 | 26,046 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 46.77 per share. | 15 Mar 2021 | 500 | 57,314 (0%) | 0% | 46.8 | 23,385 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 48.62 per share. | 05 Mar 2021 | 5,000 | 57,814 (0%) | 0% | 48.6 | 243,075 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 05 Mar 2021 | 5,000 | 62,814 (0%) | 0% | 3.2 | 16,000 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 5,000 | 34,073 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 48.58 per share. | 01 Mar 2021 | 600 | 57,814 (0%) | 0% | 48.6 | 29,148 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 16 Feb 2021 | 500 | 58,414 (0%) | 0% | 46 | 23,000 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.72 per share. | 10 Feb 2021 | 688 | 58,914 (0%) | 0% | 47.7 | 32,831 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 01 Feb 2021 | 600 | 59,602 (0%) | 0% | 44 | 26,400 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 7,500 | 58,327 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 1,875 | 60,202 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 11,500 | 23,661 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 25 Jan 2021 | 11,500 | 50,827 (0%) | 0% | 3.8 | 43,240 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 3,500 | 39,073 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 25 Jan 2021 | 3,500 | 39,327 (0%) | 0% | 3.2 | 11,200 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 51.99 per share. | 14 Jan 2021 | 4,000 | 35,827 (0%) | 0% | 52.0 | 207,960 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 57.24 per share. | 04 Jan 2021 | 600 | 39,827 (0%) | 0% | 57.2 | 34,344 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 04 Dec 2020 | 7,250 | 40,427 (0%) | 0% | 3.2 | 23,200 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 7,250 | 42,573 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 48.25 per share. | 01 Dec 2020 | 600 | 33,177 (0%) | 0% | 48.3 | 28,950 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 16 Nov 2020 | 5,750 | 33,777 (0%) | 0% | 3.2 | 18,400 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 5,750 | 49,823 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Federico Grossi | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.09 per share. | 02 Nov 2020 | 600 | 27,725 (0%) | 0% | 31.1 | 18,654 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | See Remarks | Sale of securities on an exchange or to another person at price $ 30.22 per share. | 01 Oct 2020 | 600 | 28,325 (0%) | 0% | 30.2 | 18,132 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | See Remarks | Sale of securities on an exchange or to another person at price $ 31.58 per share. | 01 Sep 2020 | 600 | 28,925 (0%) | 0% | 31.6 | 18,948 | Common Stock |
| Apellis Pharmaceuticals Inc | Federico Grossi | See Remarks | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 03 Aug 2020 | 600 | 29,525 (0%) | 0% | 26.3 | 15,768 | Common Stock |